Options
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Author(s)
Sarah K Nørgaard
Jens Nielsen
Anne Christine Nordholm
Lukas Richter
Alena Chalupka
Natalia Bustos Sierra
Toon Braeye
Maria Athanasiadou
Gleb Denissov
Oskari Luomala
Anne Fouillet
Isabelle Pontais
Matthias an der Heiden
Benedikt Zacher
Alina Weigel
Ivo Foppa
Kassiani Gkolfinopoulou
Ioannis Panagoulias
Anna Paldy
Tibor Malnasi
Lisa Domegan
Eva Kelly
Naama Rotem
Oksana Rakhlin
Francesca K de'Donato
Chiara Di Blasi
Patrick Hoffmann
Telma Velez
Kathleen England
Neville Calleja
Liselotte van Asten
Femke Jongenotter
Ana Paula Rodrigues
Susana Silva
Petra Klepac
Diana Gomez-Barroso
Inmaculada Leon Gomez
Ilias Galanis
Ahmed Farah
Rolf Weitkunat
Katarina Fehst
Nick Andrews
Tom Clare
Declan T Bradley
Mark G O'Doherty
Naoma William
Mark Hamilton
Bolette Søborg
Tyra G Krause
Nick Bundle
Lasse S Vestergaard
Abstract
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season. © 2024 European Centre for Disease Prevention and Control (ECDC).
Part Of
Eurosurveillance
Journal or Serie
Eurosurveillance
Issue
15
Volume
29
ISSN
1025496X
Date Issued
2024-04-11
Open Access
Yes
DOI
10.2807/1560-7917.ES.2024.29.15.2400178
School
Publisher
European Centre for Disease Prevention and Control (ECDC)